CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...

FDA has given Class I status to a Carefusion recall related to the Alaris Model 8100 infusion pump. A software failure in the pump had been identified in modules running software version 9.1.18. Last ...

U.S. health regulators announced a recall of CareFusion's Alaris pump module Model 8100, saying a potential keypad malfunction in the infusion pump could cause serious injury or death. The U.S. Food ...

FDA has assigned a Class I designation to a recall of CareFusion Alaris infusion pumps, originally announced last month. The agency gave the same designation to a recall of frame membranes that Elite ...

The FDA recently deemed corrective actions to three devices as Class 1, reserved for situations in which "there is a reasonable probability that the use of or exposure to a violative product will ...

The San Diego medical device company CareFusion said it received clearance from the Food and Drug Administration to resume selling its Alaris SE line of drug infusion pumps, which were pulled from the ...

August 2, 2012 — The US Food and Drug Administration (FDA) has notified healthcare professionals of a class 1 recall of the Alaris PC Unit, Model 8015, part of the Alaris electronic infusion pump. In ...

The U.S. Food and Drug Administration classified the recall of the PC unit of a certain model of the CareFusion Alaris Infusion pump as Class I on Wednesday. The ...

CHICAGO, July 10 (Reuters) - Carefusion, the medical products business being spun off by Cardinal Health Inc , said it will resume shipments of its Alaris medication infusion pumps. Shipments had been ...

(Reuters) - Health regulators announced a recall of CareFusion's Alaris pump module Model 8100, saying a potential keypad malfunction in the infusion pump could cause serious injury or death. The U.S.